OBJECTIVES: To evaluate the prevalence, characteristics, and correlates of chronic pain in a population of predominantly employed, alcoholic patients attending an outpatient drug and alcohol treatment program. METHODS: A pain survey was administered to 79 patients attending an outpatient drug and alcohol treatment program situated in a suburban community outside of New York City. Chronic severe pain was defined as pain that 1) had persisted for at least 6 months; and 2) was either moderate to severe in intensity or significantly interfered with daily activities. RESULTS: Seventy-six percent of patients experienced pain during the past week. Chronic severe pain was experienced by 29.1% of patients. High levels of pain interference with physical and psychosocial functioning were reported by 26.1%. Patients with chronic severe pain were more likely to have significant comorbidity, to cite physical pain as the impetus for alcohol or drug abuse, to have abused a prescription drug or used an illicit drug to treat pain during the prior 3 months, and to have used illicitly obtained opioids. Only 13% of patients with chronic severe pain were currently receiving pain treatment and 72% expressed interest in receiving treatment. DISCUSSION: Chronic severe pain was prevalent in this predominantly employed, alcoholic population attending an outpatient drug and alcohol treatment program. Pain was associated with significant functional impairment, medical and psychiatric comorbidities, and abuse behaviors. Few patients accessed adequate pain treatment. Efforts should be made to better address the pain problems in this patient population.
OBJECTIVES: To evaluate the prevalence, characteristics, and correlates of chronic pain in a population of predominantly employed, alcoholicpatients attending an outpatient drug and alcohol treatment program. METHODS: A pain survey was administered to 79 patients attending an outpatient drug and alcohol treatment program situated in a suburban community outside of New York City. Chronic severe pain was defined as pain that 1) had persisted for at least 6 months; and 2) was either moderate to severe in intensity or significantly interfered with daily activities. RESULTS: Seventy-six percent of patients experienced pain during the past week. Chronic severe pain was experienced by 29.1% of patients. High levels of pain interference with physical and psychosocial functioning were reported by 26.1%. Patients with chronic severe pain were more likely to have significant comorbidity, to cite physical pain as the impetus for alcohol or drug abuse, to have abused a prescription drug or used an illicit drug to treat pain during the prior 3 months, and to have used illicitly obtained opioids. Only 13% of patients with chronic severe pain were currently receiving pain treatment and 72% expressed interest in receiving treatment. DISCUSSION: Chronic severe pain was prevalent in this predominantly employed, alcoholic population attending an outpatient drug and alcohol treatment program. Pain was associated with significant functional impairment, medical and psychiatric comorbidities, and abuse behaviors. Few patients accessed adequate pain treatment. Efforts should be made to better address the pain problems in this patient population.
Authors: Declan T Barry; Mark Beitel; Christopher J Cutter; Brian Garnet; Dipa Joshi; Andrew Rosenblum; Richard S Schottenfeld Journal: J Pain Date: 2010-06-20 Impact factor: 5.820
Authors: Benjamin J Morasco; Susan Gritzner; Lynsey Lewis; Robert Oldham; Dennis C Turk; Steven K Dobscha Journal: Pain Date: 2010-12-23 Impact factor: 6.961
Authors: Judith I Tsui; Marlene C Lira; Debbie M Cheng; Michael R Winter; Daniel P Alford; Jane M Liebschutz; Jianren Mao; Robert R Edwards; Jeffrey H Samet Journal: Drug Alcohol Depend Date: 2015-05-22 Impact factor: 4.492
Authors: Katie Witkiewitz; Kevin E Vowles; Elizabeth McCallion; Tessa Frohe; Megan Kirouac; Stephen A Maisto Journal: Addiction Date: 2015-06-03 Impact factor: 6.526
Authors: Declan T Barry; Mark Beitel; Brian Garnet; Dipa Joshi; Andrew Rosenblum; Richard S Schottenfeld Journal: J Clin Psychiatry Date: 2009-07-14 Impact factor: 4.384
Authors: Declan T Barry; Jonathan D Savant; Mark Beitel; Christopher J Cutter; Brent A Moore; Richard S Schottenfeld; David A Fiellin Journal: Am J Addict Date: 2013 May-Jun